Some lncRNAs are considered to be potential promoters of MM progression, and thus, could have potential as diagnostic and prognostic biomarkers, these include LINC01215 [62], MIR222HG [62], MEG3 [63], MALAT [64], CRNDE [65], and H19 [66]. This evidence concerns the gene H19 and Miyoshi myopathy.